📈New Dataset: NR2F1 underlies persistence of residual disease in BRAF-mutant melanoma
Targeted therapies for melanoma, like BRAF and MEK inhibitors, can shrink tumors but often fail to completely eliminate all cancer cells. A small group [...]
Targeted therapies for melanoma, like BRAF and MEK inhibitors, can shrink tumors but often fail to completely eliminate all cancer cells. A small group [...]
Cut&Tag sequencing data from melanoma cells revealed that BAHCC1, a gene associated with Super-Enhancers (SE) and critical for cancer growth, is highly active compared [...]